Rheolytic Hydrodynamic Thrombectomy for Percutaneous Treatment of Acutely Occluded Infra-aortic Native Arteries and Bypass Grafts

医学 经皮 外科 截肢 血栓 穿孔 栓塞 导管 栓塞 血管造影 血管成形术 动脉 放射科 冶金 材料科学 冲孔
作者
S Müller-Hülsbeck,Marc Kalinowski,Martin Heller,H Wagner
出处
期刊:Investigative Radiology [Ovid Technologies (Wolters Kluwer)]
卷期号:35 (2): 131-131 被引量:60
标识
DOI:10.1097/00004424-200002000-00007
摘要

Müller-Hülsbeck S, Kalinowski M, Heller M, Wagner HJ. Rheolytic hydrodynamic thrombectomy for percutaneous treatment of acutely occluded infra-aortic native arteries and bypass grafts: Midterm follow-up results. Invest Radiol 2000;35:131–140. RATIONALE AND OBJECTIVES. To evaluate the efficacy of a rheolytic thrombectomy catheter (RTC) for treatment of acutely occluded infra-aortic native arteries and bypass grafts and to determine midterm primary patency, death, and amputation-free survival rates. METHODS. From March 1995 to September 1997, 112 patients with occluded arteries or bypass grafts were primarily treated with RTC at two centers. Thrombus removal was evaluated by two angiographers. RESULTS. More than 75% of the thromboembolic material could be removed with RTC alone. Mean activation time of RTC was 280 ± 163 seconds. Residual mural or organized thrombi (29%) required adjunctive fibrinolytic therapy or aspiration thrombectomy. Remaining stenoses were treated with percutaneous transluminal angioplasty and additional stent implantation. For acute reocclusions, surgical intervention was required. Technical success after the entire procedure was 88.4%. RTC-associated complications included distal embolization, dissection, vessel perforation, and technical failure of RTC. Mean follow-up time was 14.8 months ± 11.5, rates of primary patency, secondary patency, death, and amputation-free survival were 60%, 84%, 16%, and 75% after 2 years, respectively. CONCLUSIONS. RTC is a rapid and efficient technique for mechanical thrombectomy of acutely thrombosed native leg arteries and bypass grafts. Midterm results are comparable to the results of alternative treatment modalities such as Fogarty balloon thromboembolectomy or local fibrinolysis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
恶食大王王嘉然完成签到 ,获得积分10
1秒前
1秒前
Ava应助锦2022采纳,获得10
2秒前
今后应助坚定幼旋采纳,获得10
2秒前
潘啊潘完成签到 ,获得积分10
3秒前
唐唐发布了新的文献求助10
3秒前
orca完成签到,获得积分20
3秒前
4秒前
5秒前
天天发布了新的文献求助10
6秒前
7秒前
今后应助12采纳,获得10
7秒前
8秒前
8秒前
orca发布了新的文献求助10
9秒前
快帮我找找完成签到,获得积分10
10秒前
柏木了发布了新的文献求助10
10秒前
大个应助TT采纳,获得10
10秒前
11秒前
今后应助瘦瘦的帆布鞋采纳,获得10
12秒前
czz014完成签到,获得积分10
13秒前
热心市民小红花应助Tanya采纳,获得10
13秒前
ym发布了新的文献求助10
13秒前
可爱的函函应助hello采纳,获得10
13秒前
Sou发布了新的文献求助10
13秒前
14秒前
小楠楠发布了新的文献求助10
14秒前
Anddy完成签到,获得积分20
14秒前
wmy0607发布了新的文献求助10
16秒前
16秒前
夜雨声烦完成签到,获得积分10
16秒前
FOX完成签到,获得积分10
16秒前
诺澜啊发布了新的文献求助10
17秒前
虞丹萱完成签到,获得积分10
17秒前
WLX完成签到 ,获得积分10
18秒前
轻轻发布了新的文献求助10
20秒前
小七完成签到,获得积分10
21秒前
starry发布了新的文献求助10
21秒前
无知小白完成签到,获得积分10
21秒前
玛卡巴卡发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6015289
求助须知:如何正确求助?哪些是违规求助? 7592342
关于积分的说明 16148536
捐赠科研通 5163000
什么是DOI,文献DOI怎么找? 2764247
邀请新用户注册赠送积分活动 1744818
关于科研通互助平台的介绍 1634687